Continuous Flow Synthesis of a Key Intermediate Common to Gefitinib and Larotinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Continuous Flow Synthesis of a Key Intermediate Common to Gefitinib and Larotinib

Published:2024-02-20 Issue:3 Volume:28 Page:780-789
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Zhang Han¹^ORCID,Li Yifan²,Wu Xinyi¹,Wang Ning¹,Chen Xiaolin¹,Jin Yuxiang¹,Dai Fengli³,Xia Chunnian¹^ORCID

Affiliation:

1. College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, People’s Republic of China

2. University of Leeds, the edge room 24, 2 Westfield Road, Leeds LS3 1DH, U.K.

3. Zhejiang Multinpharma Co., Ltd., Hangzhou 310051, Zhejiang, People’s Republic of China

Funder

Zhejiang Multinpharma Co., Ltd

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.3c00504

Reference39 articles.

1. Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase

2. Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma

3. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus

4. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma

5. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP